GENE ONLINE|News &
Opinion
Blog

LATEST
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Reimagining the Healthcare System Innovation Ecosystem in Europe, Post-COVID
2021-10-21
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Scientists Identify Antidotes To Overcome Collateral Damage of Antibiotics on Gut Microbiota
2021-10-20
Diabetes Care Device Maker Debuts On Hong Kong Exchange
2021-10-20
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
WuXi ATU Launches Fourth Manufacturing Site for Gene and Cell Therapy CTDMO Service
2021-10-19
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
1 113 114 115 116 117 220
EVENT
Scroll to Top